Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof
US10675276B2 · kind B2 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2015 |
| Grant date | Jun 9, 2020 |
| Priority date | — |
| Expiry date | Jul 6, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to two novel oral pharmaceutical compositions of dabigatran etexilate or its pharmaceutically acceptable salts thereof, and the processes of preparation thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.